1Ruilope LM,Schiffrin EL.Blood pressure control and benefits of antihypertensive therapy:does it make a difference which agents we use[J]? Hypertension,2001,38(3Pt2):537-542.
2Shah SU,Anjum S,Littler WA.Use of diuretics in cardiovascular disease:hypertension[J].Postgrad Med J,2004,80(943):271-276.
4Wright JM.Choosing a first-line drug in the management of elevated blood pressure:what is the evidence? 3:Angiotensinconverting-enzyme inhibitors[J].CMAJ,2000,163 (3):293-296.
2Ellis ML,Patterson JH. A new class of antihypertensive therapy:angiotensin Ⅱ receptor antagonists[J].Pharmacotherapy, 1996,16 (5): 849～ 860.
3Meredith PA. Optimal dosing characteristics of the angiotensin Ⅱ receptor antagonist telmisartan [J].Am J Cardiol,1999,84(2A) :7K～12K.
4Marino MR,Langenbacher KM,Ford NE et al. Pharmacodynamics and pharmacokinetics of irbesartan in patients with mild to moderate hypertension [J]. J Cardiovasc Pharmacol Ther, 1999,4 (2): 67 ～ 75.
5Luis M,Emesto L.Blood pressure control and benefits of antihypertensive therapy-doesit make a difference which agents we use? Hypertension,2002,38(Part 2):537-542.
6Shah SU,Anjum S,Littler WA.Use of diuretics in cardiovascular disease:(2) hypertension.Postgrad Med J,2004,80:271-276.
7Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group.Diuretic versus alphablocker as first-step antihypertensive therapy:final results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).Hypertension,2003,42:239-246.
8Psaty BM,Lumley T,Furberg CD,et al.Health outcomes associated with various antihypertensive therapies used as first-line agents:a network meta-analysis.JAMA,2003,289:2534-2544.
9Wright JM.Choosing a first-line drug in the management of elevated blood pressure:what is the evidence? 1:Thiazide diuretics.CMAJ,2000,163:57-60.
10Leenen FH.ALLHAT:what has it taught us so far? CMAJ,2004,171:719-720.
